Literature DB >> 19053806

Proteomic analysis of HepaRG cells: a novel cell line that supports hepatitis B virus infection.

Ramamurthy Narayan1, Bevin Gangadharan, Olivier Hantz, Robin Antrobus, Angela García, Raymond A Dwek, Nicole Zitzmann.   

Abstract

The first proteomic characterization of the HepaRG cell line, the only cell line that is susceptible to hepatitis B virus (HBV) infection and supports a complete virus life cycle, is reported. Differential analysis of naive and HBV-infected HepaRG cells by two-dimensional gel electrophoresis revealed 19 differentially regulated features, 7 increasing and 12 decreasing with HBV infection. The proteins identified in these features were involved in various cellular pathways including apoptosis, DNA/RNA processing, and hepatocellular impairment. Similar expression changes in a number of the identified proteins have already been reported for other virus systems. Identification of these expression changes is a validation of the proteomics approach and contributes to an understanding of host cellular response to HBV infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19053806     DOI: 10.1021/pr800562j

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  13 in total

1.  The HepaRG cell line: a valuable in vitro tool for hepatitis virus infection studies.

Authors:  Liesbeth Ceelen; Marusya Lieveld; Ramses Forsyth; Mathieu Vinken
Journal:  Hepatol Int       Date:  2013-02-14       Impact factor: 6.047

2.  Proteomic analysis of primary duck hepatocytes infected with duck hepatitis B virus.

Authors:  Yanfeng Zhao; Haijing Ben; Su Qu; Xinwen Zhou; Liang Yan; Bin Xu; Shuangcheng Zhou; Qiang Lou; Rong Ye; Tianlun Zhou; Pengyuan Yang; Di Qu
Journal:  Proteome Sci       Date:  2010-06-07       Impact factor: 2.480

3.  Identification of cellular genes showing differential expression associated with hepatitis B virus infection.

Authors:  Yasuo Fukuhara; Takeshi Suda; Makoto Kobayashi; Yasushi Tamura; Masato Igarashi; Nobuo Waguri; Hirokazu Kawai; Yutaka Aoyagi
Journal:  World J Hepatol       Date:  2012-04-27

4.  Transcriptome sequencing, microarray, and proteomic analyses reveal cellular and metabolic impact of hepatitis C virus infection in vitro.

Authors:  Stephen D Woodhouse; Ramamurthy Narayan; Sally Latham; Sheena Lee; Robin Antrobus; Bevin Gangadharan; Shujun Luo; Gary P Schroth; Paul Klenerman; Nicole Zitzmann
Journal:  Hepatology       Date:  2010-08       Impact factor: 17.425

5.  Proteomic analysis of chicken embryonic trachea and kidney tissues after infection in ovo by avian infectious bronchitis coronavirus.

Authors:  Zhongzan Cao; Zongxi Han; Yuhao Shao; Heyuan Geng; Xiangang Kong; Shengwang Liu
Journal:  Proteome Sci       Date:  2011-03-08       Impact factor: 2.480

6.  Genomics and proteomics in liver fibrosis and cirrhosis.

Authors:  Rebekka A Hannivoort; Virginia Hernandez-Gea; Scott L Friedman
Journal:  Fibrogenesis Tissue Repair       Date:  2012-01-03

7.  Proteomics based identification of cell migration related proteins in HBV expressing HepG2 cells.

Authors:  Huixing Feng; Xi Li; Vincent Chan; Wei Ning Chen
Journal:  PLoS One       Date:  2014-04-24       Impact factor: 3.240

8.  Proteomic analysis of plasma membranes isolated from undifferentiated and differentiated HepaRG cells.

Authors:  Izabela Sokolowska; Cristina Dorobantu; Alisa G Woods; Alina Macovei; Norica Branza-Nichita; Costel C Darie
Journal:  Proteome Sci       Date:  2012-08-02       Impact factor: 2.480

9.  An occult hepatitis B-derived hepatoma cell line carrying persistent nuclear viral DNA and permissive for exogenous hepatitis B virus infection.

Authors:  Chih-Lang Lin; Rong-Nan Chien; Shi-Ming Lin; Po-Yuan Ke; Chen-Chun Lin; Chau-Ting Yeh
Journal:  PLoS One       Date:  2013-05-29       Impact factor: 3.240

10.  Comparative proteomics reveals novel components at the plasma membrane of differentiated HepaRG cells and different distribution in hepatocyte- and biliary-like cells.

Authors:  Catalina Petrareanu; Alina Macovei; Izabela Sokolowska; Alisa G Woods; Catalin Lazar; Gabriel L Radu; Costel C Darie; Norica Branza-Nichita
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.